OVERVIEW

International Congress on Oncology Research and Development (iCORD) is organized by Saliegral Global Pvt. Ltd. The session is held from Oct 31 - Nov 01, 2020, at Mumbai, Maharashtra, India.

Target Audience:

The conference is intended for,

• Oncologists(medical, surgical, radiological, pediatric etc)
• Industry (medical biotechnology, pharmaceutical, medical device and imaging companies)
• Cancer diagnostic and Radiological service providers including Central labs and Reading centres
• Oncologists(medical, surgical, radiological, pediatric etc)
• CROs, Hospitals, NGOs, Academia
• healthcare insurance providers

Description:
iCORD is an action and attempt to unite the industry, practising oncologists and patient support /advocacy groups to a collaborative platform to address and advocate the most advanced developments in oncology research, drugs/diagnostics, technology, therapies, and patient care programs in India. This will support cancer patients in India getting a high standard of care in parallel to global healthcare standards.

You can discover the details of this congress along with the agenda and presentation videos at the following website link: www.goicord.com.

About ICORD 2020:
• An mission to draw all stakeholders associated in cancer research and patient care to a general platform to review and address the newest advancements in oncology research, drugs/diagnostics, technology, therapies and patient care programs.
• Speakers comprises research experts from Industry, Patient Advocacy Groups and Practicing Oncologist across specialities from Asian countries – India, Singapore, China, Taiwan, Malaysia, Thailand, Korea, Vietnam, Indonesia
• Trending topics influencing the oncology research and development and clinical practices impacting Asian countries
• International Annual Event

Topics:
• Universal Health Coverage (UHC) - Ayushman Bharat - Progress so far and the road ahead
• Digital India: role in effective cancer therapy
• National Cancer Grid - How it will change cancer care in India
• Cancer Research and Development in India - SWOT analysis
• Collaborative Research in Oncology - landscape in India
• Breast cancer - Current options and newer approaches - Omics technologies in MBC
• Early breast cancer - newer treatment approaches
• Precision medicine - from molecular characterization to implementation in cancer care
• NSCLC - Standard of care and emerging trends
• The new treatment modalities of pancreatic cancers
• Immunotherapy - Indian experience - Challenges and opportunities
• Recognizing, understanding and managing immune-oncology toxicities
• Beyond Immuno checkpoint inhibitors- CAR T Cells, Immunoglobulins & oncolytic virus
• Personalized medicine in oncology
• Soft tissue sarcoma - digital treatment and other newer advances
• The era of Biomarkers
• Liquid Tumours - Lymphomas and Leukemias
• Liquid Biopsy - Pushing the frontier
• Preventative oncology
• De-escalation therapy- the other side of the coin
• Future direction of supportive and palliative care in Asia
• Freezing therapy of cancer cells
• Theragnostic Approach in cancer care
• Paediatric cancer/ supportive care
• Newest Imaging Biomarkers
• Newer cancer therapeutic approaches – Indian start-ups
• Biosimilars in India - the next wave
• Multiomics in personalised cancer treatment,
• Role of AI/ML in clinical practise,
• Affordable approached in cancer- BIG DATA
• Uniform modality of treatment in developing countries
• Ethics consideration for oncology drugs
• Patient centricity - Voice of patient